Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Ken W who wrote (28448)	4/18/2002 12:24:54 AM
From: Jibacoa	Respond to of 29382

<<ORBT is becoming a runaway train.>> Ken, for me it has been a nice and very profitable run so far. I was glad that I was able to accumulate some shares in spite of its wide spread.<g> The other nice run for me this year has been on CLHB, in which now I am enjoying a free ride, since I sold half my shares.<g> Message 17258238 siliconinvestor.com siliconinvestor.com siliconinvestor.com RAGL Bernard

To: Ken W who wrote (28448)	4/19/2002 6:31:48 PM
From: Crossy	Respond to of 29382

Ken & all, I read up your thread right now (being quite strapped on time currently) and just found you were occasionally discussing Napro.. FYI, there's a similar situation, albeit in a very early stage and also trading at ground floor on the CDNX (Canada). The company is called Bioxel Pharma, ticker BIP.V, now around $1 (Can$) I briefly mentioned this comapny many weeks ago and that I bought a chunk nar $0.80 and literally "stuffed it away". Well the shares ascended more than 20% now and on www.stockhouse.ca the rumor mill is literally spinning. According to company PR deals with pharma bellwethers have already been inked.. Now honestly, this is a pretty speculative stock and is not on the same "grade" of safety as my usual picks (like OBAS, MLTC, HAUP, TGAL most recently) however if Bioxel (BIP.V) just realizes 10% of its potential the rewards could be huge and trump the associated risk manyfold. Due to this I would recommend it as a speculative portfolio addition for any interested biomaterials/biotech investor.. best rgrds CROSSY